Correction: Cell biology (Proceedings National Academy Science USA (2014) 111, 34 (E3534-E3543) DOI: 10.1073/pnas.1405507111);Distinct isoform of FABP7 revealed by screening for retroelement-activated genes in diffuse large B-cell lymphoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 34, 2014, Pages E4630-

  Lock, Frances E ^a,b   Rebollo, Rita ^a,b   Miceli Royer, Katharine ^a,b   Gagnier, Liane ^a,b   Kuah, Sabrina ^a,b   Babaian, Artem ^a,b   Sistiaga Poveda, Maialen ^c   Lai, C Benjamin ^a,b   Nemirovsky, Oksana ^d   Serrano, Isabel ^e   Steidl, Christian ^e   Karimi, Mohammad M ^b   Mager, Dixie L ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Alternative promoters; Endogenous retroviruses; Gene regulation

Indexed keywords

CHIMERIC PROTEIN; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 7; ISOPROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; FABP7 PROTEIN, HUMAN; FATTY ACID; MESSENGER RNA; ONCOPROTEIN; RETROPOSON; RNA; TRANSPOSON; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; ENDOGENOUS RETROVIRUS; ENVIRONMENTAL CHANGE; EPIGENETIC REPRESSION; EXON; GENE CONTROL; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; ISOELECTRIC FOCUSING; LARGE CELL LYMPHOMA; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROPOSON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSPOSON; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC SCREENING; GENETICS; LYMPHOMA, LARGE B-CELL, DIFFUSE; METABOLISM; TISSUE MICROARRAY; TUMOR CELL LINE;

CARRIER PROTEINS; CELL LINE, TUMOR; DNA TRANSPOSABLE ELEMENTS; EPIGENESIS, GENETIC; FATTY ACIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC TESTING; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RETROELEMENTS; RNA, MESSENGER; RNA, NEOPLASM; TERMINAL REPEAT SEQUENCES; TISSUE ARRAY ANALYSIS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84906688503     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1512789112     Document Type: Erratum

References (79)

1. Meyerson M, Gabriel S, Getz G (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 11(10):685-696.
2. Schweiger MR, Kerick M, Timmermann B, Isau M (2011) The power of NGS technologies to delineate the genome organization in cancer: From mutations to structural variations and epigenetic alterations. Cancer Metastasis Rev 30(2):199-210.
3. Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J Pathol 223(2):102-115.
4. Guil S, Esteller M (2012) Cis-acting noncoding RNAs: Friends and foes. Nat Struct Mol Biol 19(11):1068-1075.
5. Timp W, Feinberg AP (2013) Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 13(7):497-510.
6. Levin HL, Moran JV (2011) Dynamic interactions between transposable elements and their hosts. Nat Rev Genet 12(9):615-627.
7. Biémont C, Vieira C (2006) Genetics: Junk DNA as an evolutionary force. Nature 443(7111):521-524. (Pubitemid 44527281)
8. Burns KH, Boeke JD (2012) Human transposon tectonics. Cell 149(4):740-752.
9. Bourque G, et al. (2008) Evolution of the mammalian transcription factor binding repertoire via transposable elements. Genome Res 18(11):1752-1762.
10. Kunarso G, et al. (2010) Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet 42(7):631-634.
11. Rebollo R, Romanish MT, Mager DL (2012) Transposable elements: An abundant and natural source of regulatory sequences for host genes. Annu Rev Genet 46:21-42.
12. Nigumann P, Redik K, Mätlik K, Speek M (2002) Many human genes are transcribed from the antisense promoter of L1 retrotransposon. Genomics 79(5):628-634. (Pubitemid 34499478)
13. van de Lagemaat LN, Landry JR, Mager DL, Medstrand P (2003) Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions. Trends Genet 19(10):530-536. (Pubitemid 37204911)
14. Conley AB, Piriyapongsa J, Jordan IK (2008) Retroviral promoters in the human genome. Bioinformatics 24(14):1563-1567. (Pubitemid 351966153)
15. Cohen CJ, Lock WM, Mager DL (2009) Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene 448(2):105-114.
16. Faulkner GJ, et al. (2009) The regulated retrotransposon transcriptome of mammalian cells. Nat Genet 41(5):563-571.
17. Kelley D, Rinn J (2012) Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome Biol 13(11):R107.
18. St Laurent G, et al. (2013) VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer. Genome Biol 14(7):R73.
19. Lu X, et al. (2014) The retrovirus HERVH is a long noncoding RNA required for human embryonic stem cell identity. Nat Struct Mol Biol 21(4):423-425.
20. Fort A, et al.; FANTOM Consortium (2014) Deep transcriptome profiling of mammalian stem cells supports a regulatory role for retrotransposons in pluripotency maintenance. Nat Genet 46(6):558-566.
21. Szpakowski S, et al. (2009) Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene 448(2):151-167.
22. Ross JP, Rand KN, Molloy PL (2010) Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2(2):245-269.
23. Belancio VP, Roy-Engel AM, Deininger PL (2010) All y'all need to know 'bout retroelements in cancer. Semin Cancer Biol 20(4):200-210.
24. Lamprecht B, et al. (2010) Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 16(5):571-579, 1p, 579.
25. Steinhardt JJ, Gartenhaus RB (2012) Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions. Clin Cancer Res 18(17):4538-4548.
26. Stein HWR, Chan WC (2008) Diffuse large B-cell lymphoma, not otherwise specified. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, eds Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Intl Agency Res Cancer, Lyon, France), pp 233-237.
27. Morin RD, et al. (2011) Frequent mutation of histone-modifying genes in non- Hodgkin lymphoma. Nature 476(7360):298-303.
28. Liang Y, et al. (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA 102(16):5814-5819. (Pubitemid 40559642)
29. Zhang H, et al. (2010) The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast Cancer Res Treat 121(1):41-51.
30. Seliger B, et al. (2005) Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. Proteomics 5(10):2631-2640. (Pubitemid 40966490)
31. Slipicevic A, et al. (2008) The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells. BMC Cancer 8:276-289.
32. Karimi MM, et al. (2011) DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 8(6):676-687.
33. Trapnell C, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28(5):511-515.
34. Lander ES, et al.; International Human Genome Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409(6822):860-921. (Pubitemid 32165345)
35. Toung JM, Morley M, Li M, Cheung VG (2011) RNA-sequence analysis of human B-cells. Genome Res 21(6):991-998.
36. Belshaw R, et al. (2007) Rate of recombinational deletion among human endogenous retroviruses. J Virol 81(17):9437-9442. (Pubitemid 47311486)
37. Bannert N, Kurth R (2006) The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet 7:149-173. (Pubitemid 44627926)
38. Jurka J, et al. (2005) Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res 110(1-4):462-467. (Pubitemid 41159923)
39. Smit AF (1993) Identification of a new, abundant superfamily of mammalian LTR-transposons. Nucleic Acids Res 21(8):1863-1872.
40. Diehl V, et al. (1982) Characteristics of Hodgkin' s disease-derived cell lines. Cancer Treat Rep 66(4):615-632. (Pubitemid 12129345)
41. Möller P, et al. (2001) MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphoma. Int J Cancer 92(3):348-353. (Pubitemid 32249710)
42. Pellat-Deceunynk C, et al. (1995) Human myeloma cell lines as a tool for studying the biology of multiple myeloma: A reappraisal 18 years after. Blood 86(10):4001-4002.
43. Mita R, Beaulieu MJ, Field C, Godbout R (2010) Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration. J Biol Chem 285(47):37005-37015.
44. Friedman DB, Hoving S, Westermeier R (2009) Isoelectric focusing and two-dimensional gel electrophoresis. Methods Enzymol 463:515-540.
45. Feng L, Hatten ME, Heintz N (1994) Brain lipid-binding protein (BLBP): A novel signaling system in the developing mammalian CNS. Neuron 12(4):895-908. (Pubitemid 24126249)
46. Balendiran GK, et al. (2000) Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J Biol Chem 275(35):27045-27054.
47. Liu RZ, et al. (2012) A fatty acid-binding protein 7/RXRβ pathway enhances survival and proliferation in triple-negative breast cancer. J Pathol 228(3):310-321.
48. Goto Y, et al. (2006) A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy. Cancer Res 66(8):4443-4449.
49. Iskow RC, et al. (2010) Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141(7):1253-1261.
50. Solyom S, et al. (2012) Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res 22(12):2328-2338.
51. Lee E, et al.; Cancer Genome Atlas Research Network (2012) Landscape of somatic retrotransposition in human cancers. Science 337(6097):967-971.
52. Shukla R, et al. (2013) Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 153(1):101-111.
53. Hohn O, Hanke K, Bannert N (2013) HERV-K(HML-2), the best preserved family of HERVs: Endogenisation, expression and implications in health and disease. Front Oncol 3:246.
54. Chen T, et al. (2013) The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells. Leukemia 27(7):1469-1478.
55. Maliniemi P, et al. (2013) Expression of human endogenous retrovirus-w including syncytin-1 in cutaneous T-cell lymphoma. PLoS ONE 8(10):e76281.
56. Romanish MT, Cohen CJ, Mager DL (2010) Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin Cancer Biol 20(4):246-253.
57. Piskareva O, et al. (2011) The human L1 element: A potential biomarker in cancer prognosis, current status and future directions. Curr Mol Med 11(4):286-303.
58. Cruickshanks HA, Tufarelli C (2009) Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. Genomics 94(6):397-406.
59. Wolff EM, et al. (2010) Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 6(4):e1000917.
60. Weber B, Kimhi S, Howard G, Eden A, Lyko F (2010) Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Oncogene 29(43):5775-5784.
61. Shimizu F, Watanabe TK, Shinomiya H, Nakamura Y, Fujiwara T (1997) Isolation and expression of a cDNA for human brain fatty acid-binding protein (B-FABP). Biochim Biophys Acta 1354(1):24-28. (Pubitemid 27479888)
62. Yun SW, et al. (2012) Neural stem cell specific fluorescent chemical probe binding to FABP7. Proc Natl Acad Sci USA 109(26):10214-10217.
63. Maxwell SA, Mousavi-Fard S (2013) Non-Hodgkin's B-cell lymphoma: Advances in molecular strategies targeting drug resistance. Exp Biol Med (Maywood) 238(9):971-990.
64. Wright G, et al. (2003) A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 100(17):9991-9996. (Pubitemid 37087056)
65. Choi WW, et al. (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15(17):5494-5502.
66. Kim H, Hendrickson R, Dorfman RF (1977) Composite lymphoma. Cancer 40(3):959-976. (Pubitemid 8219445)
67. Gualco G, Natkunam Y, Bacchi CE (2012) The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A description of 10 cases. Mod Pathol 25(5):661-674.
68. Li H, Ruan J, Durbin R (2008) Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18(11):1851-1858.
69. Flicek P, et al. (2014) Ensembl 2014. Nucleic Acids Res 42(Database issue):D749-D755.
70. Pruitt KD, et al. (2014) RefSeq: An update on mammalian reference sequences. Nucleic Acids Res 42(Database issue):D756-D763.
71. Rosenbloom KR, et al. (2013) ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res 41(Database issue):D56-D63.
72. Rhead B, et al. (2010) The UCSC Genome Browser database: Update 2010. Nucleic Acids Res 38(Database issue):D613-D619.
73. Rebollo R, et al. (2012) Epigenetic interplay between mouse endogenous retroviruses and host genes. Genome Biol 13(10):R89.
74. Kumaki Y, Oda M, Okano M (2008) QUMA: Quantification tool for methylation analysis. Nucleic Acids Res 36(Web Server issue):W170-175.
75. Dyer MJ, Fischer P, Nacheva E, Labastide W, Karpas A (1990) A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocations. Blood 75(3):709-714. (Pubitemid 20069213)
76. Lock FE, Ryan KR, Poulter NS, Parsons M, Hotchin NA (2012) Differential regulation of adhesion complex turnover by ROCK1 and ROCK2. PLoS ONE 7(2):e31423.
77. Drake KR, Kang M, Kenworthy AK (2010) Nucleocytoplasmic distribution and dynamics of the autophagosome marker EGFP-LC3. PLoS ONE 5(3):e9806.
78. Giambra V, et al. (2012) NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species. Nat Med 18(11):1693-1698.
79. Chambrier C, et al. (2002) Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes Res 10(6):518-525. (Pubitemid 135686644)